annual ROE:
-37.40%-23.39%(-166.95%)Summary
- As of today (September 10, 2025), DNLI annual return on equity is -37.40%, with the most recent change of -23.39% (-166.95%) on December 31, 2024.
- During the last 3 years, DNLI annual ROE has fallen by -9.89% (-35.95%).
- DNLI annual ROE is now -506.08% below its all-time high of 9.21%, reached on December 31, 2020.
Performance
DNLI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-39.36%-4.51%(-12.94%)Summary
- As of today (September 10, 2025), DNLI quarterly return on equity is -39.36%, with the most recent change of -4.51% (-12.94%) on June 30, 2025.
- Over the past year, DNLI quarterly ROE has dropped by -5.40% (-15.90%).
- DNLI quarterly ROE is now -484.75% below its all-time high of 10.23%, reached on December 31, 2020.
Performance
DNLI quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DNLI ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -166.9% | -15.9% |
| 3 y3 years | -36.0% | -34.5% |
| 5 y5 years | +10.9% | +14.1% |
DNLI ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -166.9% | at low | -230.2% | +1.8% |
| 5 y | 5-year | -506.1% | +10.9% | -484.8% | +14.1% |
| alltime | all time | -506.1% | +38.0% | -484.8% | +14.1% |
DNLI ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -39.36%(+12.9%) |
| Mar 2025 | - | -34.85%(+5.9%) |
| Dec 2024 | -37.40%(+167.0%) | -32.92%(-2.8%) |
| Sep 2024 | - | -33.87%(-0.3%) |
| Jun 2024 | - | -33.96%(+184.9%) |
| Mar 2024 | - | -11.92%(-12.2%) |
| Dec 2023 | -14.01%(-56.9%) | -13.58%(+11.9%) |
| Sep 2023 | - | -12.14%(-7.5%) |
| Jun 2023 | - | -13.12%(-67.3%) |
| Mar 2023 | - | -40.08%(+13.6%) |
| Dec 2022 | -32.52%(+18.2%) | -35.29%(+7.0%) |
| Sep 2022 | - | -32.97%(+12.6%) |
| Jun 2022 | - | -29.27%(+3.9%) |
| Mar 2022 | - | -28.18%(+2.8%) |
| Dec 2021 | -27.51%(-398.7%) | -27.40%(-1068.2%) |
| Sep 2021 | - | 2.83%(-52.3%) |
| Jun 2021 | - | 5.93%(-14.2%) |
| Mar 2021 | - | 6.91%(-32.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | 9.21%(-121.9%) | 10.23%(-124.8%) |
| Sep 2020 | - | -41.22%(-10.0%) |
| Jun 2020 | - | -45.80%(+0.8%) |
| Mar 2020 | - | -45.44%(+9.1%) |
| Dec 2019 | -41.97%(+486.2%) | -41.66%(+207.5%) |
| Sep 2019 | - | -13.55%(+22.3%) |
| Jun 2019 | - | -11.08%(+9.8%) |
| Mar 2019 | - | -10.09%(+39.4%) |
| Dec 2018 | -7.16%(-70.8%) | -7.24%(-77.2%) |
| Sep 2018 | - | -31.79%(+9.0%) |
| Jun 2018 | - | -29.17%(+28.7%) |
| Mar 2018 | - | -22.67%(-21.7%) |
| Dec 2017 | -24.49%(-59.4%) | -28.96%(-23.4%) |
| Sep 2017 | - | -37.82%(+3.1%) |
| Jun 2017 | - | -36.70%(+31.0%) |
| Mar 2017 | - | -28.01%(+42.7%) |
| Dec 2016 | -60.34%(+17.4%) | -19.63% |
| Dec 2015 | -51.38% | - |
FAQ
- What is Denali Therapeutics Inc. annual return on equity?
- What is the all time high annual ROE for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. annual ROE year-on-year change?
- What is Denali Therapeutics Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. quarterly ROE year-on-year change?
What is Denali Therapeutics Inc. annual return on equity?
The current annual ROE of DNLI is -37.40%
What is the all time high annual ROE for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high annual return on equity is 9.21%
What is Denali Therapeutics Inc. annual ROE year-on-year change?
Over the past year, DNLI annual return on equity has changed by -23.39% (-166.95%)
What is Denali Therapeutics Inc. quarterly return on equity?
The current quarterly ROE of DNLI is -39.36%
What is the all time high quarterly ROE for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high quarterly return on equity is 10.23%
What is Denali Therapeutics Inc. quarterly ROE year-on-year change?
Over the past year, DNLI quarterly return on equity has changed by -5.40% (-15.90%)